Find uplifting stories about heroes, innovations, and solutions
884 results for "cholera vaccine"
For the first time in over three years, preventive cholera vaccination campaigns are restarting worldwide as global vaccine production has doubled. Mozambique became the first country to receive doses, with 20 million vaccines now heading to three nations hit hardest by outbreaks.
For the first time in over three years, countries can now prevent cholera outbreaks before they start, thanks to doubled vaccine production. Mozambique just launched the first preventive campaign, with Bangladesh and DR Congo next in line.
Sudan just declared itself cholera-free after a massive six-month health campaign that delivered over 20 million vaccine doses during an active conflict. The victory shows what's possible when health workers refuse to give up, even in the toughest conditions.
Angola is launching a major health campaign to vaccinate nearly 88,000 people against cholera in Viana, protecting vulnerable communities from the waterborne disease. The five-day effort brings protection directly to families through door-to-door visits and community centers.
Mozambique is launching a seven-day vaccination campaign to protect 3.5 million people against cholera across nine districts. The effort comes as a powerful response to over 8,000 cases reported since October, showing swift public health action to protect vulnerable communities.
For the first time in three years, global health agencies have enough cholera vaccines to restart prevention campaigns, doubling supply from 35 million to 70 million doses annually. Mozambique just became the first country to receive life-saving doses, with Congo and Bangladesh next in line.
Despite ongoing conflict and mass displacement, Sudan has officially eliminated its cholera outbreak just five months after it began. Medical teams delivered over 20 million vaccine doses in what experts are calling a remarkable public health victory under impossible conditions.
Since the HPV vaccine became available in 2006, cervical cancer rates have dropped 27% among young American women, with some states seeing reductions over 50%. Every 10% increase in vaccination rates translates to nearly 12% fewer cancer cases.
South Carolina's largest measles outbreak in decades has officially ended after nearly 1,000 cases, and there's encouraging news: vaccination rates are climbing both locally and nationwide. Health officials say the outbreak may have reminded parents why vaccines matter.
Scientists at Washington University have created a nose spray vaccine that completely protected mice and hamsters from bird flu infection, offering hope for preventing the next pandemic. The vaccine works better than traditional flu shots and stays effective even in people who've had previous flu vaccines.
The FDA reversed its decision and will now review Moderna's groundbreaking mRNA flu vaccine, marking a potential leap forward in flu prevention. This could bring the same technology that revolutionized COVID vaccines to seasonal flu shots.
California health officials are encouraging at-risk residents to get vaccinated against mpox as case rates have more than quadrupled compared to last year. The vaccine provides strong protection against both strains of the virus, and most new infections are happening in unvaccinated people.
A groundbreaking trial shows Moderna's new mRNA flu vaccine is 27% more effective than traditional flu shots, offering hope for better protection during flu season. The technology's faster production could mean vaccines that better match circulating strains.
African countries have prevented nearly one million cervical cancer deaths through expanded HPV vaccination programs since 2019, while new malaria vaccines are saving thousands of children across 25 nations. These historic health wins are generating $1.8 billion in economic benefits, though funding gaps now threaten to slow the momentum.
Scientists are fast-tracking three promising vaccines to fight the Ebola outbreak in Congo and Uganda, with clinical trials starting within months. New funding of $62 million is speeding up development of the first vaccines specifically designed for the Bundibugyo virus strain.
Iceland, Portugal, and Norway have reached the ambitious target of vaccinating 90% of girls against HPV by age 15, bringing cervical cancer elimination within reach. Since 2020, every European country has reported declining cervical cancer rates among vaccinated women. #
An FDA committee greenlighted next year's flu vaccine formulation this week, maintaining the proven update process while vaccine policy debates swirl in Washington. The decision keeps Americans on track for seasonal flu protection.
South Africa is expanding its lifesaving HPV vaccination campaign to reach every girl in the country, protecting them from cervical cancer that kills over 3,000 women annually. Since 2014, the program has already vaccinated 3.6 million girls with more than 7.2 million doses administered.
After a century with only one TB vaccine, three promising candidates are in final trials, led by South African researchers who could deliver a breakthrough by 2028. The new vaccines could prevent millions of deaths from a disease that still kills over 1.5 million people yearly.
Republican pollsters are finding overwhelming voter support for vaccines and immunization programs, helping to slow aggressive policy changes. New data shows most Americans reject vaccine skepticism and support keeping childhood vaccination recommendations.
Showing 20 of 884